TVHS opens stem cell processing lab to expand biotherapies | VA Tennessee Valley health care | Veterans Affairs Veterans Affairs
TVHS opens stem cell processing lab to expand biotherapies | VA Tennessee Valley health care | Veterans Affairs Veterans Affairs
Drawing on its increasing understanding of tissue or organ-specific stem cells , the institute is exploring the ability of these cells to replenish or repair damaged or congenitally abnormal tissues or organs. Tissue-specific stem cells may one day be used to replenish cells damaged by Parkinson's disease, Alzheimer's disease, multiple sclerosis or diabetes. One example of tissue regeneration is in bone marrow transplants, where blood-forming stem cells regenerate the blood of transplant recipients who receive otherwise lethal doses of chemotherapy to destroy all the cancer cells in the body
Abstract Stem cells are defined as precursor cells that have the capacity to self-renew and to generate multiple mature cell types. Only after collecting and culturing tissues is it possible to classify cells according to this operational concept. This difficulty in identifying stem cells in situ, without any manipulation, limits the understanding of their true nature. This review aims at presenting, to health professionals interested in this area, an overview on the biology of embryonic and adult stem cells, and their therapeutic potential. Keywords: adult stem cells, biological characteristics, cell therapy, embryonic stem cells, human diseases Although the initial concept of stem cells is more than 100 years old,1 and much of its biology and therapeutic potential has been explored in the past three decades, we still know little about their true nature.
New government tech deals boost the business of cancer detection GOV.UK
Stem cell therapy reverses type 1 diabetes in world first Yahoo News UK
Advances in different adult stem cell-derived exosomal non-coding RNAs for the treatment of neurological disorders: a narrative review Frontiers
Breakthrough technique may help speed understanding, treatment of MD, ALS Harvard Gazette
Rostock University Explores Use of Stem Cells for Meat Cultivation with Help from Innocent Meat vegconomist - the vegan business magazine
Continued here: Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program
Follow this link: Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024
Recent Comments